Jonathan Govette, Founder and CEO of Oatmeal Health The Persistent Challenge of Healthcare Access and Cancer Screening Disparities In the United States, the healthcare landscape remains plagued by significant disparities, particularly for underserved populations….
Continue Reading
Introduction
Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, has made a significant move to bolster its leadership team by appointing Teri Thomas as Chief Business Officer (CBO) of its Cancer…
Introduction
Delphinus Medical Technologies, a pioneering company in medical imaging, has announced the results of a groundbreaking study on the efficacy of its SoftVue Breast Ultrasound Tomography (UST) system. This study compared the cancer detection…
Enhancing ambulance response using MLNew research at the Victoria University of Wellington seeks to apply machine learning models to improve emergency response times.
Backed by a grant from New Zealand’s Ministry of Business, Innovation and…
Color Health, a genetic testing company, is using OpenAI’s newest, less expensive, large language model to equip doctors with pretreatment workup expertise that could speed up prior authorization requests for cancer screening diagnostics and…
Continue Reading
Breast cancer screening is vital in reducing mortality rates associated with the disease. However, traditional mammography, despite its effectiveness, often results in false positives, leading to unnecessary stress and procedures for patients. A recent…
Continue Reading
What You Should Know:
– Color Health, a leader in comprehensive cancer care, announced today that it is partnering with SkinIO and Bexa to integrate their innovative solutions for skin and breast cancer screening into…
Continue Reading
North Central London Integrated Care Board (ICB) has partnered with the Islington GP Federation and digital health firm SPRYT to pilot the use of WhatsApp combined with AI to streamline cervical cancer screening and…
Continue Reading
Diagnostics startup Geneoscopy earned its first-ever FDA approval this week.
The St. Louis-based company received approval for ColoSense, its noninvasive colorectal cancer screening test. The test — which the FDA designated as a breakthrough device…
Continue Reading
Among the already available liquid biopsy test is aimed at early detection of colorectal cancer. Colorectal cancer screening is crucial due to the high incidence and mortality rates of the disease, which is increasingly…
Continue Reading
